Genomic Profiling of Early Stage Breast Cancer: Expanding Applications to Improve Outcomes

This webinar will empower you with data demonstrating the utility of Agendia’s assays, MammaPrint® and BluePrint®, for patients with breast cancer. Review the latest data and learn about the real-world impact of MammaPrint and BluePrint. Please join us for an informative, interactive webinar.

The views, information, or opinions expressed during this presentation are solely those of the individuals involved and do not necessarily represent those of Agendia, Inc.